FDA Okays Tablet Version of Acalabrutinib for All Indications
The US Food and Drug Administration has approved AstraZeneca's new tablet formulation of acalabrutinib (Calquence) for all current indications of ...
The US Food and Drug Administration has approved AstraZeneca's new tablet formulation of acalabrutinib (Calquence) for all current indications of ...
Men with localized prostate cancer that is treated with radiotherapy have a small but statistically elevated risk for a second ...
Short-course antibiotics are sufficient for most patients, concludes an open-label trial that compared a 3-day course of antibiotics with an extended ...
INDIANAPOLIS – An investigational topical treatment for dystrophic epidermolysis bullosa (DEB) known as beremagene geperpavec (B-VEC) showed durable and statistically ...
A new, industry-funded consensus statement from an international team of hematologists, oncologists, and cardio-oncologists urges caution regarding the cardiac risks ...
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.
© 2022 Medical News Hubb All rights reserved.